This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
US large, mid, and small-cap retirement index funds provide layered exposure to varying market segments. This intro covers allocation ideas and risk considerations.
26,127 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Investing in obesity drugs doesn't have to be a gamble. This guide explains why a proven company with real cash flow ...
Salesforce just announced a massive buyback, but does that mean now is the time to buy CRM stock? This guide breaks d...
Counterfeit money can slip into everyday transactions and end up funding gift cards via fraud. This guide explains th...
Gen Z is departing San Francisco for Texas and Florida, triggering a new wave where welcomer cities like Nashville an...
The memory-chip rally cools as prices soften and demand slows. This report weighs Micron, SanDisk, and Applied Materi...
A disciplined, six‑stock dividend plan could turn $100,000 into reliable annual income. Here's the latest layout, yie...
In a turbulent market, five Dividend Kings have continuously raised payouts for more than half a century, underscorin...
Interactive Brokers grew customer accounts by 34% in the last year, signaling strong momentum in a competitive discou...
Two March data drops could tease the next cost-of-living adjustment for social security retirees, even though the off...
Geopolitical strains in the Gulf collide with political turbulence in Washington, delivering a fresh round of market ...
Oil prices hold near the high-$80s to low-$90s as the Hormuz disruption tests supply buffers. Market resilience is fu...